Literature DB >> 7742853

Fate of the upper urinary tract in multiple sclerosis.

N G Kasabian1, I Krause, W E Brown, Z Khan, H M Nagler.   

Abstract

Urologic problems are a major source of morbidity for patients with multiple sclerosis (MS). Fifty-four to 78% of patients experience bladder symptoms which are due to spinal lesions interrupting neural pathways that control micturition. MS patients could have upper or lower motor neuron lesion type bladders. Both obstructive and irritative symptoms may be present. Although lower urinary tract dysfunction has been well described in MS, few studies have investigated the fate of the upper urinary tract. Thirty-two patients with MS were referred for urodynamic evaluation. Twenty-six of the 32 patients had upper urinary tract studies performed. Only 1 of the 26 patients had evidence of upper urinary tract deterioration. It is our impression that upper tract deterioration occurs infrequently in these patients. We discuss clinical clues that may predict deterioration.

Entities:  

Mesh:

Year:  1995        PMID: 7742853     DOI: 10.1002/nau.1930140113

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

1.  Urologic manifestations of multiple sclerosis: proposed treatment algorithms.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Clinical management of the neurourological syndrome associated with multiple sclerosis and correlations to grade of the disease.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Quality of life in women with multiple sclerosis and overactive bladder syndrome.

Authors:  Giuseppe Quarto; Riccardo Autorino; Antonio Gallo; Marco De Sio; Massimo D'Armiento; Sisto Perdonà; Rocco Damiano
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-05-13

Review 4.  Management of neurogenic bladder in patients with multiple sclerosis.

Authors:  Véronique Phé; Emmanuel Chartier-Kastler; Jalesh N Panicker
Journal:  Nat Rev Urol       Date:  2016-03-31       Impact factor: 14.432

5.  Bladder Dysfunction in Iranian Patients with Multiple Sclerosis.

Authors:  Mohaddeseh Azadvari; Seyede Zahra Emami Razavi; Masumeh Shahrooei; Abdorreza Naser Moghadasi; Amirreza Azimi; Hamid Reza Farhadi-Shabestari
Journal:  J Multidiscip Healthc       Date:  2020-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.